NOVEL USE OF N-SUBSTITUTED SULFONYL INDOLE DERIVATIVE COMPOUND

PROBLEM TO BE SOLVED: To provide a pharmaceutical composition that comprises an N-substituted sulfonyl indole derivative compound having proliferation inhibitory action for a wide range of cancer cells as an active ingredient.SOLUTION: An anticancer agent pharmaceutical composition comprises an N-su...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SUZUKI YUTARO, KAMIMURA DAISUKE, WATABE TAEKO, KAWAZOE YOSHINORI, ABE TAKAHIRO, YAMADA KAORU
Format: Patent
Sprache:eng ; jpn
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SUZUKI YUTARO
KAMIMURA DAISUKE
WATABE TAEKO
KAWAZOE YOSHINORI
ABE TAKAHIRO
YAMADA KAORU
description PROBLEM TO BE SOLVED: To provide a pharmaceutical composition that comprises an N-substituted sulfonyl indole derivative compound having proliferation inhibitory action for a wide range of cancer cells as an active ingredient.SOLUTION: An anticancer agent pharmaceutical composition comprises an N-substituted sulfonyl indole derivative compound represented by the formula (1), having B12 melanoma cell proliferation inhibitory activity, where R is a lower alkyl group, an aryl group which may be substituted, or a heteroaryl group which may be substituted. 【課題】広範な癌細胞に対する増殖抑制作用を有するN−置換スルフォニルインドール誘導体化合物を有効成分として含有する医薬組成物の提供。【解決手段】式(1)で表されるB12メラノーマ細胞増殖阻害活性を有するN−置換スルフォニルインドール誘導体化合物を含有する抗癌剤医薬組成物。[Rは低級アルキル基、置換していてもよいアリール基、又は置換していてもよいヘテロアリール基]【選択図】なし
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2015168619A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2015168619A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2015168619A3</originalsourceid><addsrcrecordid>eNrjZLDz8w9z9VEIDXZV8HdT8NMNDnUKDvEMCQ1xdVEIDvVx8_eL9FHw9HPx93FVcHEN8gxzDPEMc1Vw9vcN8A_1c-FhYE1LzClO5YXS3AxKbq4hzh66qQX58anFBYnJqXmpJfFeAUYGhqaGZhZmhpaOxkQpAgDUNCr3</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NOVEL USE OF N-SUBSTITUTED SULFONYL INDOLE DERIVATIVE COMPOUND</title><source>esp@cenet</source><creator>SUZUKI YUTARO ; KAMIMURA DAISUKE ; WATABE TAEKO ; KAWAZOE YOSHINORI ; ABE TAKAHIRO ; YAMADA KAORU</creator><creatorcontrib>SUZUKI YUTARO ; KAMIMURA DAISUKE ; WATABE TAEKO ; KAWAZOE YOSHINORI ; ABE TAKAHIRO ; YAMADA KAORU</creatorcontrib><description>PROBLEM TO BE SOLVED: To provide a pharmaceutical composition that comprises an N-substituted sulfonyl indole derivative compound having proliferation inhibitory action for a wide range of cancer cells as an active ingredient.SOLUTION: An anticancer agent pharmaceutical composition comprises an N-substituted sulfonyl indole derivative compound represented by the formula (1), having B12 melanoma cell proliferation inhibitory activity, where R is a lower alkyl group, an aryl group which may be substituted, or a heteroaryl group which may be substituted. 【課題】広範な癌細胞に対する増殖抑制作用を有するN−置換スルフォニルインドール誘導体化合物を有効成分として含有する医薬組成物の提供。【解決手段】式(1)で表されるB12メラノーマ細胞増殖阻害活性を有するN−置換スルフォニルインドール誘導体化合物を含有する抗癌剤医薬組成物。[Rは低級アルキル基、置換していてもよいアリール基、又は置換していてもよいヘテロアリール基]【選択図】なし</description><language>eng ; jpn</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20150928&amp;DB=EPODOC&amp;CC=JP&amp;NR=2015168619A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20150928&amp;DB=EPODOC&amp;CC=JP&amp;NR=2015168619A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SUZUKI YUTARO</creatorcontrib><creatorcontrib>KAMIMURA DAISUKE</creatorcontrib><creatorcontrib>WATABE TAEKO</creatorcontrib><creatorcontrib>KAWAZOE YOSHINORI</creatorcontrib><creatorcontrib>ABE TAKAHIRO</creatorcontrib><creatorcontrib>YAMADA KAORU</creatorcontrib><title>NOVEL USE OF N-SUBSTITUTED SULFONYL INDOLE DERIVATIVE COMPOUND</title><description>PROBLEM TO BE SOLVED: To provide a pharmaceutical composition that comprises an N-substituted sulfonyl indole derivative compound having proliferation inhibitory action for a wide range of cancer cells as an active ingredient.SOLUTION: An anticancer agent pharmaceutical composition comprises an N-substituted sulfonyl indole derivative compound represented by the formula (1), having B12 melanoma cell proliferation inhibitory activity, where R is a lower alkyl group, an aryl group which may be substituted, or a heteroaryl group which may be substituted. 【課題】広範な癌細胞に対する増殖抑制作用を有するN−置換スルフォニルインドール誘導体化合物を有効成分として含有する医薬組成物の提供。【解決手段】式(1)で表されるB12メラノーマ細胞増殖阻害活性を有するN−置換スルフォニルインドール誘導体化合物を含有する抗癌剤医薬組成物。[Rは低級アルキル基、置換していてもよいアリール基、又は置換していてもよいヘテロアリール基]【選択図】なし</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLDz8w9z9VEIDXZV8HdT8NMNDnUKDvEMCQ1xdVEIDvVx8_eL9FHw9HPx93FVcHEN8gxzDPEMc1Vw9vcN8A_1c-FhYE1LzClO5YXS3AxKbq4hzh66qQX58anFBYnJqXmpJfFeAUYGhqaGZhZmhpaOxkQpAgDUNCr3</recordid><startdate>20150928</startdate><enddate>20150928</enddate><creator>SUZUKI YUTARO</creator><creator>KAMIMURA DAISUKE</creator><creator>WATABE TAEKO</creator><creator>KAWAZOE YOSHINORI</creator><creator>ABE TAKAHIRO</creator><creator>YAMADA KAORU</creator><scope>EVB</scope></search><sort><creationdate>20150928</creationdate><title>NOVEL USE OF N-SUBSTITUTED SULFONYL INDOLE DERIVATIVE COMPOUND</title><author>SUZUKI YUTARO ; KAMIMURA DAISUKE ; WATABE TAEKO ; KAWAZOE YOSHINORI ; ABE TAKAHIRO ; YAMADA KAORU</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2015168619A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; jpn</language><creationdate>2015</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SUZUKI YUTARO</creatorcontrib><creatorcontrib>KAMIMURA DAISUKE</creatorcontrib><creatorcontrib>WATABE TAEKO</creatorcontrib><creatorcontrib>KAWAZOE YOSHINORI</creatorcontrib><creatorcontrib>ABE TAKAHIRO</creatorcontrib><creatorcontrib>YAMADA KAORU</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SUZUKI YUTARO</au><au>KAMIMURA DAISUKE</au><au>WATABE TAEKO</au><au>KAWAZOE YOSHINORI</au><au>ABE TAKAHIRO</au><au>YAMADA KAORU</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NOVEL USE OF N-SUBSTITUTED SULFONYL INDOLE DERIVATIVE COMPOUND</title><date>2015-09-28</date><risdate>2015</risdate><abstract>PROBLEM TO BE SOLVED: To provide a pharmaceutical composition that comprises an N-substituted sulfonyl indole derivative compound having proliferation inhibitory action for a wide range of cancer cells as an active ingredient.SOLUTION: An anticancer agent pharmaceutical composition comprises an N-substituted sulfonyl indole derivative compound represented by the formula (1), having B12 melanoma cell proliferation inhibitory activity, where R is a lower alkyl group, an aryl group which may be substituted, or a heteroaryl group which may be substituted. 【課題】広範な癌細胞に対する増殖抑制作用を有するN−置換スルフォニルインドール誘導体化合物を有効成分として含有する医薬組成物の提供。【解決手段】式(1)で表されるB12メラノーマ細胞増殖阻害活性を有するN−置換スルフォニルインドール誘導体化合物を含有する抗癌剤医薬組成物。[Rは低級アルキル基、置換していてもよいアリール基、又は置換していてもよいヘテロアリール基]【選択図】なし</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; jpn
recordid cdi_epo_espacenet_JP2015168619A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title NOVEL USE OF N-SUBSTITUTED SULFONYL INDOLE DERIVATIVE COMPOUND
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T13%3A28%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SUZUKI%20YUTARO&rft.date=2015-09-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2015168619A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true